Abstract
Alemtuzumab is a humanized CD52-specific monoclonal antibody that is increasingly used off-label as an induction agent in solid organ transplantation, particularly in the setting of maintenance immunosuppression minimization protocols. In this review, we briefly discuss this agent's mechanisms of action and summarize evidence supporting its use in this clinical setting.
| Original language | English |
|---|---|
| Pages (from-to) | 1545-1547 |
| Number of pages | 3 |
| Journal | Transplantation |
| Volume | 84 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2007 |
Keywords
- Alemtuzumab
- Immunosuppression
- Lymphocyte depletion
- Monoclonal antibody
Fingerprint
Dive into the research topics of 'Alemtuzumab'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver